Assessing the cost utility of response-guided therapy in patients with chronic hepatitis C genotype 1 in the UK using the MONARCH model

Phil McEwan, Ray Kim, Yong Yuan

Research output: Contribution to journalArticle

35 Scopus citations

Fingerprint Dive into the research topics of 'Assessing the cost utility of response-guided therapy in patients with chronic hepatitis C genotype 1 in the UK using the MONARCH model'. Together they form a unique fingerprint.

Business & Economics

Medicine & Life Sciences